Pivotal bioVenture Partners Investment Advisor LLC
Venture CapitalPosition in RLYB — Rallybio Corp
CIK 1844645
SAN FRANCISCO, CA
Position in RLYB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,809,264
+$2,113,071 QoQ
Shares Held
300,579
0.0% QoQ
Ownership
5.66%
of shares outstanding
% of Portfolio
1.56%
of 13F equity value
Holder Rank
#6
of 37 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RLYB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pivotal bioVenture Partners Investment Advisor LLC holds $291,774,212 across 12 Biotechnology names. RLYB ranks #11 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
1,425,470 | $82,862,571 | |
| 2 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,265,283 | $33,175,720 | |
| 3 | TRVI |
Trevi Therapeutics, Inc.
|
1,742,672 | $32,500,832 | |
| 4 | AVLN |
Avalyn Pharma Inc.
|
966,792 | $31,826,792 | |
| 5 | EVMN |
Evommune, Inc.
|
1,926,943 | $25,609,072 | |
| 6 | MPLT |
MapLight Therapeutics, Inc.
|
611,446 | $21,914,224 | |
| 7 | OCS |
Oculis Holding AG
|
1,506,250 | $20,891,687 | |
| 8 | IMNM |
Immunome Inc.
|
732,512 | $15,521,929 |
All Filings in RLYB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,809,264 | 300,579 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,696,193 | 300,579 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,649,585 | 2,404,644 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,199,917 | 2,404,644 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $812,769 | 2,404,644 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,575,041 | 2,404,644 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,308,458 | 2,404,644 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,813,433 | 2,404,644 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,222,222 | 2,404,644 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,448,591 | 2,404,644 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $5,747,099 | 2,404,644 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,103,650 | 2,404,644 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $13,610,285 | 2,404,644 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $13,730,517 | 2,404,644 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $15,798,511 | 2,404,644 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $32,865,870 | 2,271,311 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $17,148,398 | 2,271,311 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $15,853,750 | 2,271,311 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $21,668,306 | 2,271,311 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $39,929,647 | 2,271,311 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||